Substance Use Disorder
Continuity of Care
Coordinating long-term recovery across transitions of care: managing relapse, medications, and follow-up after the acute encounter.
What Is a Substance Use Disorder?
A Substance Use Disorder (SUD) is a chronic, relapsing condition defined by continued substance use despite significant harm. It is diagnosed using the DSM-5 criteria across four domains.
The Four DSM-5 Domains
Why Continuity Matters
Core Rule: Start & Continue MAT
Medication-Assisted Treatment (MAT) is first-line for opioid and alcohol use disorder. The Step 3 principle: do not stop maintenance medication abruptly at transitions of care — continue it across every handoff.
First-Line Medications
| Mechanism | Key Caution | |
|---|---|---|
| Buprenorphine | Partial μ-agonist | Precipitated withdrawal if given too early |
| Methadone | Full μ-agonist | QT prolongation; clinic-dispensed only |
| Naltrexone | μ-antagonist | Requires 7–10 days opioid-free first |
| Acamprosate | Glutamate modulation | Renally cleared; adjust in CKD |
Key Distinction: Naltrexone vs Buprenorphine
A Continuity-Care Checklist
Example 1: The Discharge Plan
A 34-year-old with opioid use disorder is stabilized on buprenorphine-naloxone in the hospital and is ready for discharge. What ensures continuity?
Example 2: Relapse Math
After a missed dose, a patient's risk of relapse rises. If baseline 6-month relapse probability without maintenance is \( p = 0.65 \) and MAT cuts it by 40%, the maintained probability is:
Example 3: The Antagonist Pitfall
A patient who used heroin 3 days ago requests naltrexone to "stay clean." What is the correct continuity-of-care decision?
Common Mistakes
Continuity Summary
| Opioid Use Disorder | Alcohol Use Disorder | |
|---|---|---|
| First-line MAT | Buprenorphine / methadone | Naltrexone / acamprosate |
| Acute caution | Withdrawal timing | CIWA-guided benzo taper |
| Overdose kit | Naloxone always | Thiamine before glucose |
| Continuity goal | No gaps in agonist | Behavioral + medication |
Check Your Understanding
Question 1 of 5
A patient on stable buprenorphine maintenance is admitted for surgery. What is the best continuity-of-care approach to the buprenorphine?
Question 2 of 5
A patient with opioid use disorder who used 2 days ago wants to start medication. Which is most appropriate?
Question 3 of 5
Which intervention should accompany every discharge for a patient with opioid use disorder?
Question 4 of 5
For a patient with severe alcohol use disorder and stage 3 CKD, which first-line maintenance medication is preferred?
Question 5 of 5
If unmaintained 6-month relapse risk is \( p = 0.70 \) and MAT reduces it by 50%, the maintained relapse risk is: